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Background: Characterizing large genomic variants is essential to expanding the research and clinical applications
of genome sequencing. While multiple data types and methods are available to detect these structural variants (SVs),
they remain less characterized than smaller variants because of SV diversity, complexity, and size. These challenges are
exacerbated by the experimental and computational demands of SV analysis. Here, we characterize the SV content of a
personal genome with Parliament, a publicly available consensus SV-calling infrastructure that merges multiple data
types and SV detection methods.
Results: We demonstrate Parliament’s efficacy via integrated analyses of data from whole-genome array comparative
genomic hybridization, short-read next-generation sequencing, long-read (Pacific BioSciences RSII), long-insert (Illumina
Nextera), and whole-genome architecture (BioNano Irys) data from the personal genome of a single subject (HS1011).
From this genome, Parliament identified 31,007 genomic loci between 100 bp and 1 Mbp that are inconsistent with
the hg19 reference assembly. Of these loci, 9,777 are supported as putative SVs by hybrid local assembly, long-read
PacBio data, or multi-source heuristics. These SVs span 59 Mbp of the reference genome (1.8%) and include 3,801
events identified only with long-read data. The HS1011 data and complete Parliament infrastructure, including a
BAM-to-SV workflow, are available on the cloud-based service DNAnexus.
Conclusions: HS1011 SV analysis reveals the limits and advantages of multiple sequencing technologies, specifically
the impact of long-read SV discovery. With the full Parliament infrastructure, the HS1011 data constitute a public
resource for novel SV discovery, software calibration, and personal genome structural variation analysis.
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Analysis of personal genome sequence variation data is
currently dominated by single-nucleotide variant (SNV)
and small insertion and deletion (indel) detection. Such
variants are easily visualized, relatively straightforward to
detect, and have driven many successful studies of the
associations between genomic variation and human disease
[1-3]. Larger variants, however, account for a greater
number of variable bases in the genome, with up to
13% of the human genome subject to such variation
[4]. These structural variants (SVs) include copy-number
variants (CNVs), copy-number neutral inversions, mobile
element insertions (MEIs), deletions, translocations, and
complex combinations of these events. Given their scope,
it is unsurprising that SVs have been implicated in a broad
variety of diseases and are thought to contribute greatly to
human genetic and phenotypic diversity [5]. Nevertheless,
structural variation remains less understood and more
challenging to detect and characterize than SNVs and
smaller indels, both across populations and in personal
genomes. As whole-genome sequencing (WGS) becomes
increasingly employed as a research and molecular
diagnostic tool, complete and accurate characterization of
human genomic variation, including SVs, will be essential
to informing clinical decision making.
CNVs, as represented by deviations from the normal
diploid state, are the most thoroughly studied class of
SVs, with extensive evidence for their role in human
health and disease [6-8]. When encompassing genic
regions, CNVs can alter the dosage and regulation of
their constituent genes, while non-genic CNVs can affect
the expression of proximal genes [4,9,10]. Moreover,
genic CNVs can contribute to recessive carrier states
[11,12] or bring about disease in combination with SNVs
on alleles in trans [3,13-17]. However, the resolution of
CNV loci derived from array-based data is limited by
probe density. Read-depth analysis of whole-exome
sequence (WES) data has proven comparable to
array-based CNV detection methods, but WES CNV
calls still lack base-pair resolution of breakpoint junctions
[18]. High-resolution SV breakpoint determination is
necessary to understanding the disruptive (as opposed
to dosage) effects of SVs when their breakpoints fall
within functional genomic elements [19], to identifying
“mutational signatures” of SV formation mechanisms [20],
and to obtain both orientation and genomic positional
information for CNV gains.
The availability of NGS data has resulted in a menagerie
of SV-detection tools reflecting the broad size range,
diversity, and complexity of SVs [21]. These SV-detection
methods are often limited by algorithm design, by the
underlying data, and restricted to analysis of SVs of a
certain type, location, or size. Recent efforts to address these
limitations integrate multiple methods (e.g., paired-end,split-read, read-depth, and reference-sequence techniques)
to identify consensus SVs [8,22-24]. While such consensus
SV callers possess the ability to accommodate various data
types and input formats, they are largely designed to
call SVs from the most ubiquitous type of sequence
data, paired-end (PE) reads, which are generally shorter
(~100 bp) than most SVs.
The challenges of SV detection are exacerbated by the
lack of a “gold standard” description of structural variation
within a personal genome—a reference diploid genome
does not exist. Here we combine PE and aCGH data with
long-read, long-insert, and whole-genome architecture
data from a single individual (HS1011) to improve the
scope, resolution, and reliability of SV identification in a
personal genome. These data are analyzed via established
and newly developed SV discovery tools and then merged
and evaluated within Parliament, a SV detection infra-
structure designed for multiple data sources and discovery
methods. The constituent HS1011 data, the resulting set
of SV calls, and the Parliament infrastructure are publicly
available for local download and on the cloud-based service
DNAnexus, allowing users to compare novel methods
to this analysis of HS1011 and readily analyze other




To provide a robust characterization of structural
variation in a human personal genome, we examined mul-
tiple data sources from a single individual (HS1011). This
individual has been previously analyzed with aCGH data
and by whole-genome and whole-exome sequencing,
revealing novel SH3TC2 SNVs causative for the sub-
ject’s autosomal recessive Charcot-Marie-Tooth (CMT)
neuropathy [25,26].
PE sequence and aCGH data were combined with
long-read, long-insert size, and genome architecture data to
describe the structural variation in the HS1011 genome.
Table 1 summarizes the previously collected whole-genome
data for HS1011 and the new data specific to this study: a
4.2 million probe aCGH assay, 10X Pacific Biosciences
(PacBio) long-read coverage, an Illumina Nextera
long-insert library (2X read coverage), and 51X coverage
by BioNano Irys single-molecule data. In aggregate, these
data represent ~300 billion sequenced nucleotides (~90X)
and 7.3 million aCGH probes covering the HS1011
genome. These technologies and their corresponding SV
information were next integrated using Parliament, a
novel analysis infrastructure (Figure 1b). The SV-detection
methods employed by Parliament identify regions of a
subject’s genome that are inconsistent with a reference
haploid genome assembly. These inconsistencies either
can arise from true variation between the subject and
Table 1 HS1011 data sources
Data Type Resolution Source
WGS Illumina HiSeq NGS 48X 100x100 bp paired-end [26]
WGS Illumina Nextera NGS 2X 100x100 bp 6.5 kbp mate-pair inserts Methods
WGS SOLiD NGS 3X 35 bp fragment 10X 25x25 bp paired-end 17X 50x50 bp paired-end [25,26]
WGS PacBio Long-Read 10X ~10,000 bp Methods
Agilent 1 M aCGH 1-million-probe oligo array [26]
NimbleGen 2.1 M aCGH 2.1-million-probe oligo array [26]
NimbleGen 4.2 M aCGH 4.2-million-probe oligo array Methods
Custom Agilent Exon Array aCGH 44,000 neuropathy-specific oligo array [26]
BioNano Irys Genome Mapping Single-molecule genome architecture Methods
Sanger-Validated Deletions Manual 42 fully resolved deletions Methods
Previously published HS1011 data are indicated with literature references, and data new to the present work are described in Methods.
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between the subject’s reads and reference data.
The Parliament discovery step identified 47,706 initial
events in the size range of 100 bp to 1 Mbp that reduced
to 31,007 reference-inconsistent loci, spanning 4.8% ofFigure 1 Parliament workflows. The Parliament infrastructure is designed t
(a) Novel Method evaluation incorporates new data or methods to the HS1
requiring only a paired-end WGS BAM file as input.the HS1011 genome. To distinguish between structural
variants and mapping artifacts, we performed local
hybrid assembly with the short- and long-read data
(48X Illumina HiSeq and 10X PacBio RS, respectively).
Local hybrid assembly supported 7,708 loci, that is, at leasto incorporate multiple data types and software for each data type.
011 workflow. (b) The HS1011 workflow. (c) The Illumina Only workflow,
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given locus. Recognizing the limitations of local assembly,
we then identified 1,103 unassembled loci with support
from different technologies and 966 unassembled loci with
support from only one technology (excluding PacBio) that
are spanned by at least one PacBio read consistent
with the predicted SV. In total, these 9,777 SVs had
an aggregate length of approximately 93 Mbp that
span 59 Mbp of the reference genome (1.8%). Table 2
summarizes the performance of each data source and
discovery method that contributes to the HS1011 SVs.
The utility of the multi-source approach is immediately
apparent, with single data types contributing 68.1%
(6,654/9,777) of the SVs. PBHoney, developed specifically
to identify SVs from long-read PacBio data [27], alone
discovered 3,801 SVs with assembly support, indicating
the importance of read length when characterizing
structural variation. Additional file 1: Table S1 provides a
complete summary of all 31,007 reference-inconsistent
loci, which include the 9,777 Parliament SVs and 21,230
unsupported loci.
The HS1011 SVs comprised 5,044 deletions, 4,463
insertions, and 270 inversion events. Figure 2 compares
the size distributions of HS1011 deletions and insertions
with those reported in other personal genomes [28,29].
The HS1011 distributions exhibit peaks at ~300 bp, aTable 2 Parliament HS1011 summary
Source Method Data Reference Total
calls
BreakDancer Paired End Illumina HiSeq [43] 6,474
CNVnator Read Depth Illumina HiSeq [44] 6,232
Crest Split Read Illumina HiSeq [45] 2,490
Delly Paired End &
Split Read
Illumina HiSeq [23] 4,465
Pindel Paired End Illumina HiSeq [46] 5,728
SV-STAT Reference-guided
Assembly
Illumina HiSeq Methods 893
Tiresias Consensus
Sequences
Illumina HiSeq Methods 1,354




PBHoney Local Error and
Tail Mapping













Descriptions and results for each SV-detection method are provided. BioNano Irys d
size and propensity to span multiple events.characteristic of Alu transposon dimorphisms [30]. We
assessed all HS1011 events larger than 100 kbp by
manually examining the Irys architecture data in the
corresponding regions. The Irys data were consistent
with 15 events ranging from 100,000 bp to 154,971 bp.
Given the resolution and nature of the Irys data, it is
unlikely that a large insertion or deletion would not
manifest itself in the genomic architecture.
SV corroboration
Parliament’s integration of multiple data sources and
local hybrid assembly provides a systematic assessment
of the SV calls made by each program. Each of the
31,007 reference-inconsistent loci was assessed based on
three support characteristics, each with a corresponding
bit value: assembly support (+4), multi-source support
(+2), and long-read force calling (+1). These bit values
represent an ordinal prioritization of support types.
Combining these bit values for each locus results in a
bitflag between 0–7, which provides a compact, extensible,
and easily parsed representation of all possible support
type combinations. For example, a locus with no support
would have a 0 bitflag, while a locus with both assembly
and multi-source support would have a bitflag of 6 (4 + 2).
The 9,777 SVs comprised all loci with non-zero bitflags.












5,520 1,740 335 194 104 82
6,197 679 402 130 176 109
2,219 1,636 138 115 8 3
3,720 1,150 323 196 109 97
4,451 2,432 244 359 421 206
892 754 90 32 9 1
1,347 269 36 112 76 110
1,881 1,626 100 98 76 14
17,765 3,751 788 814 979 622
10,340 5,883 483 0 3,792 0
4,785 490 454 211 96 211
1,960 231 452 8 30 8
343 201 142 0 41 0
31,184 7,733 1,133 1,033 4,897 841
ata was used only for corroboration, not initial discovery, owing to its large
Figure 2 Size distribution. All HS1011 SV events larger than 100 bp and less than 100,000 bp were compared to events from the Venter genome
(HuRef) and an Asian Male (YH), both specifically characterized for SV content. In this size regime, the HS1011, HuRef, and YH samples contain
5044, 5127, and 5374 deletions (panel a) and 4482, 4479, and 15525 insertions (panel b), respectively. The YH SV distributions are based on de
novo assembly of 35 bp single-end and paired end data. This assembly was used to identify SVs between 1 bp and 50 kbp. Initial events larger
than 50 bp were filtered using discordant paired-end mapping of ~35 bp reads. Given the relative abundance of HS1011 sequence data
(including both long reads and longer short reads as compared to the YH short reads), and given the differences in methods, it is unlikely that
the ~3-fold difference in insertions between the YH set and the HS1011 and HuRef sets represents a significant lack of Parliament sensitivity.
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aCGH data in a family trio. Figure 3 illustrates that of the
9,777 HS1011 SVs, 4,352 matched to a DGV event. The
remaining 5,425 HS1011 SVs that did not match a DGV
entry reflect either previously uncharacterized SVs or the
low resolution of many DGV events. Thus, as with SNVs
[31], many SVs in a personal genome represent rare or
private variants not observed in databases [11]. We also
identified 2,263 unsupported loci that match with DGV
events. While these events may correspond to potential
HS1011 false negative SVs, they may also be the result of
common mapping artifacts represented as variants in
DGV or incidental overlap of the DGV events, which
cover 70% of the human genome.We next compared the deletion calls to SNVs identi-
fied based on WGS Illumina sequencing data by using
runs of homozygous SNVs as proxy (homozScore) for
deleted regions. HomozScore refers to the fraction of
homozygous SNVs in a deleted region (see Methods). We
focused on deletions within autosomes that encompassed
five or more SNVs. Figure 4 indicates that the supported
SV set (i.e., 5,044 deletions with non-zero bitflags) is
enriched for deletions consistent with SNV data. For
deletions in this supported set that have average coverage
less than 25X, we identified 59% (96/161) with homoz-
Score >0.8. In contrast, for the unsupported (i.e., 0 bitflag)
deletions only 18% (260/1,426) have a homozScore >0.8,
reflecting identification of false positive deletion calls. To
Figure 3 DGV comparison. Each of the 31,007 reference-inconsistent loci was characterized as either an HS1011 SV or unsupported locus based on its
Parliament bitflag and as either “In DGV” or “Not DGV” based on whether it shared at least 50% reciprocal overlap with a DGV event of the same type.
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HS1011 deletions that share 90% reciprocal overlap with a
high-confidence set of population deletions from the 1000
Genomes Project [32]. Of these 54 deletions, 52 have a
homozScore > 0.8.
To further assess deletion detection and assembly
accuracy, we experimentally validated 42 deletions
that were amenable to long-range PCR and sequen-
cing. These deletions had an average size of 10.6 kbp
(min_size = 3,139 bp and max_size = 53,924 bp; median =
7,613 bp), calculated from exact breakpoints determinedFigure 4 SNP concordance. HomozScores are reported for three classes of
coverage, HS1011 SVs with greater than 50X coverage.by Sanger sequencing. The average difference between
the Sanger and Parliament breakpoints for these
events was 44 bp, and the median difference was 2 bp
(Additional file 1: Table S2). These values may be subject
to alignment ambiguities caused by repeat-mediated break-
points or microhomology generated by rearrangement
mechanisms such as Fork Stalling Template Switching
(FoSTeS) or microhomology mediated break induced repli-
cation (MMBIR) [33,34]. For example, our largest deviation
was 1,065 bp for an event mediated by two L1PA5-L1
repeats with 90% identical sequence. We used the same 42HS1011 deletion loci: unsupported loci, HS1011 SVs with less than 25X
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data from the subject’s parents [25]. Of these 42, all were
confirmed in at least one parent and 17 are found in both
(Additional file 2: Figures S1 and S2), indicating no de novo
mutations in this small subset.
Exonic SV content
We investigated whether SVs were enriched in exonic
regions, limiting this analysis to events smaller than
100 kbp to avoid large-event bias. The 31,007
reference-inconsistent loci include 30,573 loci less
than 100 kbp that span 88,832,602 bp of the genome
(2.7%). Of these loci, 1,859 cover 1,021,515 bp of
5,035 exons (2.8% of the total exonic sequence). Similarly,
9,566 of the supported SVs are less than 100 kbp,
spanning 22,898,826 bp (0.7% of the genome). Of these
SVs, 293 span 270,537 bp of 1,372 exons (0.7% of the total
exonic sequence). These similar values do not suggest
exonic enrichment for either the reference-inconsistent
loci or the HS1011 SVs. Table 3 lists all genes with exons
intersecting an assembly-supported SV (i.e., bitflag >=4)
that is not found in DGV. A full list of exons overlapping
SVs is provided in Additional file 1: Table S3.
Multi-source comparison
To further elucidate the impact of long-read data on SV
detection, we developed a parallel Illumina workflow
(Figure 1c) that uses only Illumina HiSeq PE data for
both SV discovery and local assembly evaluation. This
workflow (IllOnly) identified 17,706 reference-inconsistent
loci, 3,082 of which were supported by local Illumina-only
assembly. We then assessed each of the 17,706 IllOnly loci
with local Illumina/PacBio hybrid assembly support.
The IllOnly Parliament workflow was 86.41% accurate,
97.92% specific, and 57.34% sensitive, with 2,824 of the
3,082 IllOnly SVs supported by hybrid assembly
(Additional file 1: Table S4). We also recovered 2,101
SVs that lacked IllOnly assembly support but were
supported by hybrid assembly (Figure 5). Table 4
compares the false-discovery rates (FDRs) and sensitivities
of each Illumina HiSeq SV method and the Parliament
IllOnly workflow. Parliament is the only method with less
than 10% FDR and greater than 50% sensitivity. Despite
these benefits of a multi-algorithm approach, Illumina-only
discovery still only recovers approximately half of the 9,777
SVs identified by multi-source Parliament: PBHoney
alone identifies 4,268 SVs supported by hybrid assembly,
representing events “invisible” to PE data.
Figure 6 illustrates the performance of all source-pair
combinations relative to hybrid assembly and DGV events.
Calls supported by only one data source are represented
on the diagonals, which indicate that such events were
both less likely to match a DGV event or have assembly
support. All aCGH events, solo or paired, were more likelythan other event types to have a DGV match, despite no
clear preference in the assembly data. This disparity is
likely a combination of the challenges associated with
assembling larger events identified by aCGH and the
prevalence of such calls in DGV.
Parliament on DNAnexus
Implementation of Parliament on local compute requires
independent installation of multiple discovery tools
and a local assembler, imposing a burden of systems
administration and resource consumption. We therefore
installed the suite on a cloud-based service via DNAnexus,
a commercial middle-ware provider. In this implementa-
tion, users need only to upload their data, select the
desired tools, and adjust Parliament parameters. Currently,
DNAnexus supports a full version of Parliament as well as
a lightweight BAM-to-SV workflow that requires only
Illumina paired-end WGS data.
All HS1011 data used in this study and the full result
set are also available on DNAnexus to facilitate software
development and benchmarking. These data and the
Parliament infrastructure compose a publicly available
resource for developers wishing to evaluate novel SV
detection methods in a scalable environment (Figure 1a).
Users can either upload their HS1011 result set in
Parliament format or create a DNAnexus app to run a
newly developed program directly in the Parliament
workflow. In either case, Parliament will update the
HS1011 reference-inconsistent loci with the novel events
and reassemble any new or modified loci with the Illumina
and PacBio data, reporting the novel method’s performance
relative to the existing data set.
Discussion
Previous single genome analyses have used combinations
of array, unpaired short-read, and PE data to identify
large variants [28-30,35-39]. A diploid de novo assembly
of a single individual (HuRef ) identified 8,152,407 bp
that are structurally variable when compared to the
version 36 human genome reference assembly [37].
However, subsequent application of SV detection methods
to array and PE data identified an additional 40,625,059
structurally variant base pairs that, when compared to
other genomic characterizations, suggest the limitations
of assembly, PE data, and array based SV-detection
methods [28].
As the number of personal genomes increases in the
clinical setting, overcoming the limitations of SV discovery
will be critical for diagnosing genetic disease. Even with
the variety of methods and depth of data applied here to
HS1011, resolving SVs in a personal genome remains a
challenge. While Parliament was designed to provide the
most comprehensive set of SVs for a genome given all
available data, the HS1011 results also point the way
Table 3 Exonic SVs with assembly support absent
from DGV
Gene Chr Start End Type Source Flag
ASTN1 1 177,131,105 177,139,508 INS ARR,ILL,PAC 7
C16orf96 16 4,619,222 4,629,905 INS ARR,ILL,PAC 7
DOCK3 3 50,879,021 50,879,201 INS ILL,PAC 7
PCNXL4 14 60,575,443 60,575,546 INS ILL,PAC 7
PKD1L3 16 72,030,321 72,032,511 INS ILL,PAC 7
TBC1D3G 17 34,805,579 34,815,084 DEL ILL,PAC 7
MAGEA11 X 148,735,694 148,830,894 MIS ILL,NEX 6
METTL21C 13 103,345,467 103,348,148 INS ILL,NEX 6
RAP1GDS1 4 99,179,171 99,184,420 DEL ARR 5
ZNF826P 19 20,504,301 20,595,300 DEL ILL 5
ASTN1 1 177,131,101 177,139,495 MIS ILL 5
C20orf96 20 258,785 260,245 DEL ARR 5
CSMD3 8 113,234,275 113,239,237 DEL NEX 5
GMCL1 2 70,066,401 70,071,781 MIS NEX 5
HLA-DRB1 6 32,547,848 32,548,158 DEL ILL 5
MLF1IP 4 185,651,743 185,652,393 INS ILL 5
MTO1 6 74,203,747 74,216,637 MIS ILL 5
MUC2 11 1,092,829 1,093,579 INS ILL 5
OR4C6 11 55,431,550 55,457,289 INS ILL 5
PDE4DIP 1 144,954,098 144,960,871 MIS ILL 5
RAB11FIP3 16 544,841 547,158 INS NEX 5
AP2A2 11 915,248 928,463 INS ARR 4
TPSB2 16 1,274,089 1,288,819 INS ARR 4
TPSG1 16 1,274,089 1,288,819 INS ARR 4
ALDH16A1 19 49,966,580 49,968,737 INS NEX 4
ASMTL X 1,550,501 1,572,400 INS ILL 4
C14orf39 14 60,913,981 60,941,067 MIS ILL 4
CCL24 7 75,438,336 75,451,936 INS ILL 4
CD99 X 2,651,401 2,699,500 INS ILL 4
CNTNAP3B 9 43,844,101 43,866,100 INS ILL 4
CTNNA2 2 80,769,022 80,780,356 MIS ILL 4
DEFA1 8 6,833,701 6,844,000 DEL ILL 4
DSPP 4 88,536,463 88,536,667 INS ILL 4
ENPP7 17 77,699,565 77,726,581 MIS ILL 4
EXOC6B 2 72,688,192 72,697,903 MIS ILL 4
FAM186A 12 50,745,742 50,745,861 INS PAC 4
FOXO6 1 41,847,826 41,847,932 INS PAC 4
FRK 6 116,274,618 116,307,096 MIS ILL 4
HERC2 15 28,547,301 28,566,700 INS ILL 4
HSD17B3 9 99,057,917 99,063,709 MIS ILL 4
IFNAR1 21 34,694,683 34,701,442 MIS NEX 4
IGHV4-61 14 107,087,259 107,099,190 INS ILL 4
IL28A 19 39,730,613 39,762,849 MIS NEX 4
Table 3 Exonic SVs with assembly support absent
from DGV (Continued)
IL28B 19 39,730,613 39,762,849 MIS NEX 4
IL3RA X 1,494,601 1,510,800 INS ILL 4
KIAA1671 22 25,441,077 25,467,572 INS ILL 4
KRT37 17 39,579,211 39,595,476 MIS ILL 4
KRT38 17 39,579,211 39,595,476 MIS ILL 4
KRTAP4-7 17 39,240,740 39,240,840 INS PAC 4
KRTAP5-4 11 1,642,915 1,643,128 INS PAC 4
MATR3 5 138,652,720 138,666,146 INS ARR 4
NBPF15 1 148,571,852 148,591,725 INS ARR 4
OR2A7 7 143,945,501 143,956,800 INS ILL 4
OR2G6 1 248,682,789 248,702,341 MIS NEX 4
OR4C3 11 48,340,701 48,347,600 INS ILL 4
OR4C6 11 55,431,551 55,445,867 INS PAC 4
OR8U1 11 56,143,129 56,143,999 INS PAC 4
PLXNB2 22 50,723,862 50,724,455 DEL ILL 4
PPP2R3B X 290,201 300,100 INS ILL 4
PPP2R3B X 327,401 344,700 INS ILL 4
PRIM2 6 57,494,250 57,507,908 INS ILL 4
RFC1 4 39,350,151 39,353,407 INS NEX 4
RGPD3 2 107,082,401 107,085,300 DEL ILL 4
RRBP1 20 17,639,769 17,639,981 INS PAC 4
SAMD1 19 14,200,852 14,200,953 INS PAC 4
SHOX X 598,001 628,300 INS ILL 4
SLC25A6 X 1,494,601 1,510,800 INS ILL 4
SMC1B 22 45,745,435 45,746,440 INS ILL 4
TMEFF2 2 192,818,912 192,840,053 MIS ILL 4
UTS2D 3 190,999,450 191,019,577 INS ILL 4
XG X 2,651,401 2,699,500 INS ILL 4
ZNF208 19 22,156,807 22,156,912 DEL PAC 4
ZNF253 19 19,990,342 20,005,317 MIS ILL 4
ZNF346 5 176,462,777 176,474,191 INS ILL 4
ZNF519 18 14,105,158 14,105,265 DEL PAC 4
Genomic location, SV type, Parliament bitflag, and supporting data types are
provided for the 75 HS1011 SVs overlapping an exon but not matching a
DGV event.
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many assembly-supported calls are made only from
short-read or long-read methods, lacking multi-source
support. Inspection of several of these events indicates
that short- and long-read mappability and long-read
coverage could account for some single-source discovery
of HS1011 SVs (Additional file 2: Figure S4). To further
refine the HS1011 SVs, future Parliament analysis will
incorporate additional short- and long-read coverage
and short-read libraries of varying insert sizes. These
additional data will allow us to better distinguish
Figure 5 Illumina-Only & PacBio comparison. The Illumina only
results are compared to the HS1011 SV subset containing Illumina
and PacBio discovery. PB-ILL contains all HS1011 SVs with PacBio or
Illumina discovery and hybrid assembly support. The ILLHyb workflow
uses only PE methods for discovery but both Illumina and PacBio
sequence reads for local assembly. The ILLOnly workflow uses only
Illumina PE methods and reads for both discovery and assembly.
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data themselves, identify optimal data characteristics
for SV discovery, and better characterize existing SVs
(e.g., evaluate zygosity, differentiate overlapping but
distinct alleles, resolve complex events, eliminate false
positives).
Array-based calls present a different set of challenges,
as aCGH provides neither orientation nor positional
information, but rather reports a value relative to a
control and thus can identify CNVs but not copy-number
neutral SVs such as inversions. Moreover, a relative gain
in a subject could correspond to a loss in the controlTable 4 Illumina-only method comparison
Program Total
called
Supported Unsupported FDR Sensitivity
CNVnator 6,197 1,211 4,986 80.46% 22.62%
BreakDancer 5,520 2,269 3,251 58.89% 42.39%
Delly 3,720 1,669 2,051 55.13% 31.18%
Crest 2,219 1,889 330 14.87% 35.29%
Pindel 4,451 3,035 1,416 31.81% 56.70%
SV-STAT 892 876 16 1.79% 16.36%
Tiresias 1,347 417 930 69.04% 7.79%
Spiral 1,881 1,824 57 3.03% 34.07%
Parliament 3,082 2,852 258 8.37% 57.34%
Performance for each Illumina-only method is summarized. Supported and
Unsupported columns indicate the number of calls with and without local
hybrid assembly support, respectively. False discovery rate (FDR) and sensitivity
are calculated using all 17,704 Illumina Only reference inconsistent loci and the
subset of 5,584 that are supported by hybrid assembly.genome. Finally, gains reported by aCGH do not specify
the exact location of those gains, only the portion of the
genome that shows the relative gain; clinical aCGH and
FISH studies reveal insertional translocations occur
160X more frequently than previously thought [40].
To characterize gains, these duplicated regions would
have to be compared to all possible insertion location
to confirm the nature of the event. Future work will
include incorporating such non-local variant annotation,
which will also improve the size estimates of events repre-
sented as distant breakpoints.
Development of such variant annotation will also include
improved resolution of complex genomic rearrangements
(CGRs) [41]. Figure 7 describes a CGR in HS1011 identified
by PE-only methods as separate events. Manual examin-
ation of the macaque (BGI CR_1.0/rheMac3) and
chimpanzee (CSAC 2.1.4/panTro4) genomes revealed
that the organization of this syntenic locus was similar to
that reconstructed from HS1011. In the chimpanzee
genome a large gap encompasses the relative position of
the deletion event. Examination of a fosmid mapping
resource available for hg18 [42] shows that 9 of 9 genomes
contain deletion, inversion, and insertion fosmids at this
locus. Therefore, the rearrangement found in HS1011
may be the common allele, or the hg19 reference may
represent an erroneous sequence at this locus.
While further refinement of the HS1011 data will
increase the specificity of the SV set, it is unlikely that
high-throughput personal genome SV characterizations
will have access to all the HS1011 data types. As with
SNVs, we can enrich for SVs of interest by incorporating
corroborating data, such as family data, runs of homozy-
gosity, and phenotype-specific gene lists. With this in
mind, our Illumina-only SV detection workflow built
within the Parliament prioritizes putative SV events based
on the degree of support (Parliament bitflag) rather than
assigning a threshold for “truth.” Such prioritization is
particularly appropriate for SVs considering that any SV
with purported clinical impact will likely undergo manual
curation or orthogonal validation. Moreover, as reported
here, applying multiple technologies and methods to a
personal genome still only reveals the tens of thousands of
reference-inconsistent loci that could indicate the
presence of structural variation. While the calls made
by different Illumina HiSeq methods largely overlap,
there are 1,601 HS1011 SVs identified by only one
method, more than 10% of the total events (Table 2).
Considering the millions of potential SNVs whole
genome data yield and the desire to recover potentially
rare and complex events, SV detection methods can afford
to err on the side of sensitivity.
The Parliament workflows described here were designed
for single-sample analysis of HS1011, but the Parliament
infrastructure is amenable to multi-source data. By
Figure 6 Multi-source comparison. Each cell contains the number of clusters with support from a pair of sources. The diagonal entries describe
clusters with support with exactly one data source.
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data, Parliament can subtract calls common to mul-
tiple samples to create tumor-normal or trio analysis
Parliament workflows. Given large sample sets, the
Parliament discovery step can be performed in parallel on
each sample, merging the resultant calls into a “master
list” of sites that can be assessed via local assembly in each
sample, providing a project-level summary of structural
variation across the cohort.Figure 7 Complex rearrangement. A representation of a large-scale deletio
depicted. Through de novo assembly, the rearrangement breakpoint junctio
genome of HS1011 was found to be as depicted. Below are shown the junConclusions
Decreasing sequencing costs, a diversity of resequencing
technologies, and increased availability of powerful com-
putational resources provide an immediate opportunity
to examine a broader class of genomic variation beyond
SNVs in the exome. The present work identifies upper
(4.5%) and lower (1.8%) estimates of the extent of structural
variation in a personal genome and characterizes the
impact of various resequencing methods. Applying multiplen and inverted insertion rearrangement on chromosome 11 p15.5 is
ns (Jct 1, 2, and 3) were identified, and the resultant structure in the
ction sequences of the three breakpoints.
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integration is optimal for SV detection in Illumina
paired-end data, the addition of long-read data can
more than triple the number of SVs detectable in a
personal genome. The 9,777 SVs identified from the
HS1011 data sources represent the first long-read
characterization of structural variation in a diploid
human personal genome. Moreover, The HS1011 genome
is particularly applicable to the challenges facing SV
characterization, not for its specific SV content but
because of the diversity of data and the ability to collect
even more data as new technologies arise. The HS1011 data
and the Parliament infrastructure are available via
DNAnexus, lowering barriers to evaluate new SV-detection
methods. In turn, each method evaluated via Parliament in
this data commons further refines the HS1011 SV data
set—improving the desired gold standard characterization
of SVs in a personal diploid human genome.
Methods
Sample data
Tables 1 and 2 provide references for previously collected
data and published methods, respectively. Informed con-
sent was obtained for individual HS1011 under protocol H-
29697, which is approved by the Institutional Review Board
at Baylor College of Medicine. This protocol provides con-
sent to publish the detailed genomic information contained
in this manuscript. Sequence data for HS1011 (BioSample
SAMN00009513) can be obtained via the SRA database
(accession numbers SRX286419, SRX852867, SRX852868,
and SRX852869).
Illumina Nextera
The WGS Illumina Nextera data is 100 × 100 bp mate
pair with an average fragment size of 6.5 kbp providing
71X clone coverage and approximately 2X read coverage.
Pacific Biosciences
Large-insert PacBio library preparation was conducted
by following the User Bulletin - Guidelines for Preparing
20 kbp SMRTbell™ Templates (version 2) and Procedure
& Checklist - 20 kbp Template Preparation Using
BluePippin Size-Selection (version 3) listed in the web-
site (http://www.pacificbiosciences.com/support/pubmap/
documentation.html). In brief, a total of 120 ug genomic
HS1011 DNA was sheared into 20 kbp targeted size
by using Covaris g-TUBEs (Cat.# 520079, Covaris) on
Eppendorf 5424 centrifuge. Each shearing processed
10 ug input DNA and a total of 12 shearings were
performed. The sheared genomic DNA was examined
by Agilent 2100 Bioanalyzer DNA12000 Chip (Cat.#
5067–1508, Agilent Technologies Inc.) for size distribution
and underwent DNA damage repair/end repair, blunt-end
adaptor ligation followed by exonuclease digestion. Thepurified digestion products were loaded onto pre-cast
0.75% agarose cassettes (Cat.# BHZ7510, Sage Science) for
7–50 kbp size selection using BluePippin Size Selection
System (Cat.# BLU0001, Sage Science), and the recovered
size-selected library products were purified using 0.5x
pre-washed Agencourt AMPure XP beads (A63880,
Beckman Coulter). The final libraries were examined by
Agilent 2100 Bioanalyzer DNA12000 Chip for size distri-
bution and the library concentrations were determined by
Qubit 2.0 Fluorometer (Cat.# Q32866, Life Technologies).
BioNano Irys
Cells were washed with PBS, resuspended in cell resuspen-
sion buffer, and embedded in gel plugs (BioRad #170-3592).
Plugs were incubated with lysis buffer and proteinase K for
four hours at 50°C. The plugs were washed and then
solubilized with GELase (Epicentre). The purified
DNA was subjected to four hours of drop dialysis. It
was quantified using Nanodrop 1000 (Thermal Fisher
Scientific) and/or Quant-iT dsDNA Assay Kit (Invitrogen/
Molecular Probes), and the quality was assessed using
pulsed-field gel electrophoresis.
DNA was labeled according to commercial protocols
using the IrysPrep Reagent Kit (BioNano Genomics, Inc.).
Specifically, 300 ng of purified genomic DNA were nicked
with 7U nicking endonuclease Nt.BspQI (New England
BioLabs, NEB) at 37°C for two hours in NEB Buffer 3. The
nicked DNA was labeled with a fluorescent-dUTP nucleo-
tide analog using Taq polymerase (NEB) for one hour at
72°C. After labeling, the nicks were ligated with Taq ligase
(NEB) in the presence of dNTPs. The backbone of fluores-
cently labeled DNA was stained with YOYO-1 (Invitrogen).
The DNA was loaded onto the nanochannel array of
the BioNano Genomics IrysChip by electrophoresis of
DNA. Linearized DNA molecules were then imaged auto-
matically followed by repeated cycles of DNA loading using
the BioNano Genomics Irys system.
The DNA molecules backbones (YOYO-1 stained) and
locations of fluorescent labels along each molecule were
detected using the in-house software package, IrysView.
The set of label locations of each DNA molecule defines
an individual single-molecule map.
Single-molecule maps were assembled de novo into con-
sensus maps using tools developed at BioNano Genomics.
Briefly, the assembler is a custom implementation of the
overlap-layout-consensus paradigm with a maximum likeli-
hood model. An overlap graph was generated based on
pairwise comparison of all molecules as input. Redundant
and spurious edges were removed. The assembler outputs
the longest path in the graph and consensus maps were
derived. Consensus maps are further refined by mapping
single molecule maps to the consensus maps and label
positions are recalculated. Refined consensus maps are
extended by mapping single molecules to the ends of
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initial maps. After merging of overlapping maps, a final
set of consensus maps was output and used for subse-
quent analysis (Additional file 2: Figure S3).
Alignments between consensus maps were obtained
using a dynamic programming approach where the scoring
function was the likelihood of a pair of intervals being
similar. Likelihood is calculated based on a noise model
which takes into account fixed sizing error, sizing error
which scales linearly with the interval size, misaligned sites
(false positives and false negatives), and optical resolution.
An interval or range of intervals whose cumulative
likelihood is worse than 0.01 percent is classified as
an outlier region. If such regions occur between highly
scoring regions, an insertion or deletion call is made in
the outlier region, depending on the relative size of
the region on the query and reference maps.
At present, the BioNano assembly approach is agnostic to
allelic bias when calling SVs, and all Irys SV calls are pre-
sumed to the homozygous. The BNG de novo assembly ap-
proach chooses a single haploid when representing a flattened
reference model (which is the current BNG standard), pre-
sumably the allele that is present in the majority of molecules.
Array comparative genomic hybridization
Genomic DNAs of all four members of the family were uti-
lized to perform aCGH using a variety of high-resolution
platforms to detect CNVs in the family quartet. NA10851
DNA obtained from a cell line from Coriell Cell Repositories
(http://ccr.coriell.org) was used as control for the compara-
tive genomic hybridization for all individuals and platforms.
Agilent 1 M whole-genome aCGH
Array comparative genomic hybridization (aCGH) using
Agilent’s 1 Million whole-genome high-density oligo-
nucleotide microarrays containing one million probes
across the genome was performed in the four members of
the quartet and two additional siblings. Briefly, samples
and control DNAs (2500 ng) were digested with the
enzymes AluI and RsaI. Following digestion, the sample
DNAs were labeled with Cy5-dCTP and the control
DNAs were labeled with Cy3-dCTP using the BioPrime
Array CGH genomic labeling kit (Invitrogen Corporation,
Carlsbad, CA, USA). Purification of and quatitation of the
labeled genomic DNA was performed and samples and
controls were matched accordingly. Sample plus control
labeled DNAs were mixed with human Cot-I DNA for
blocking unspecific hybridization and mixed in blocking
and hybridization buffers according to the manufacturer’s
protocol. After pre-hybridization incubation, the labeled
DNAs were deposited on the 1 M array slide for competi-
tive hybridization to take place for 40 hours at 65°C.
Washing, scanning, and data feature extraction were
conducted according to the manufacturer’s protocol.NimbleGen 4.2 M whole-genome aCGH
NimbleGen’s 4.2 Million whole-genome array platform
was also used on the four members of the quartet.
Briefly, genomic DNAs for samples and control (0.5 ug)
were labeled using the manufacturer’s Cy3 (test sample)
or Cy5 (control) labeled random nonamers. Labeled
products were precipitated, purified and combined
(sample + control) for competitive hybridization on the
array slide at 42°C for 72 hours. After hybridization,
washing, scanning, image processing and data extraction
were conducted according to the manufacturer’s protocol
and software.
PCR amplification and sequencing of breakpoints
Specific PCR primers based on the aCGH and SOLiD
sequencing CNV calls were designed. Standard end-point
and long-range PCR reactions were performed in order to
amplify the specific CNV breakpoints. Sanger sequencing
was done on all of the successfully amplified PCR
products in order to elucidate the specific sequence
and coordinates where the breakpoints occurred.
Software
Structural Variation detection by STAck and Tail
(SV-STAT) is a reference-guided assembler that detects
and ranks SVs at nucleotide resolution. First the algorithm
catalogs candidate breakpoints, the genomic coordinates
and orientations of which are determined by recurrent
partial alignments, or “stacks.” Next, SV-STAT generates
a fasta-formatted library of candidate junctions by
concatenating breakpoint regions in orders and orienta-
tions consistent with otherwise discordant read-pairs. The
algorithm’s metric for a candidate is a function of the
difference between the scores of alignments A and B,
where A is the alignment between a “stacked” read and
the reference, and B is a re-alignment of the same read to
the candidate junction. Full details will be reported
elsewhere. For the purposes of this study, SV-STAT
used the predictions of BreakDancer to determine the
paired genomic regions in which to search. In this
way, SV-STAT provided a ranking of BreakDancer
predictions according to the support available at nucleo-
tide resolution. The source code for SV-STAT is publically
available (https://gitorious.org/svstat).
Structural Variation Assessment of CHRomosomal
Aberrations (SVachra) is a breakpoint-calling program
that uses discordant mate pair reads consisting of both
inward and outward facing read types, for example, the
data delivered by Illumina mate pair and Nextera
Tagmentation sequencing libraries. The SVachra program
calculates the distributions of the inward and outward
facing mate pair types and applies independent clus-
tering of the inward and outward facing discordant
mapped reads to call chromosomal aberrations. Both
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of SV, reporting. SVachra calls large insertions-deletions,
inversions, inter- and intra-chromosomal translocations,
reporting breakpoints in the inward facing orientation
thereby eliminating the contradictory outward facing
read orientations. SVachra Source code is available at
http://github.com/oliverhampton/SVachra.
Tiresias identifies mobile element insertions using
clusters of improperly mapped read pairs comprising
one read that maps uniquely to the genome and one that
maps to a set of element-specific consensus sequences.
Breakpoints consistent with each cluster are then identi-
fied as local genomic positions with multiple termini of
soft-clipped reads.
Data mapping and alignment of the original SOLiD WGS
sequence data were performed using Life Technologies’
(former Applied Biosystems) SOLiD Software and Corona
Lite suite. Illumina WGS data were mapped and aligned
using the BCM HGSC Mercury pipeline (See Appendix 3).
All other additional analyses were performed using custom
Perl scripts for data parsing, comparison, extraction and
intersection.
Standardization
To compare the SV calls made by each program, all calls
are first reduced to one of three types: deletion, insertion,
and mismatch. Deletions correspond to any regions in the
sample that are missing sequence that is locally present in
the reference, insertions are regions with more sequence
than the reference, and mismatches contain different
sequence than the reference (e.g., inversions). Reduced re-
sults are stored in a VCF-like format (http://sourcefor-
ge.net/projects/parliamentsv/), and these files are then
loaded into a SQLite database and clustered in a method-
and data-sensitive manner.
Events with reference sequence spans (deletions
and mismatches) are clustered using source-specific
minimum reciprocal overlap thresholds. For example,
the Illumina-based BreakDancer and CNVnator programs
both generate calls of similar precision and such calls are
grouped if they possess >50% reciprocal overlap. However,
Bionano Irys calls contain only outer boundaries, while
Crest calls contain exact breakpoints, so the Irys-Crest
threshold is 20% reciprocal overlap. Exact breakpoint
resolution of zero reference-span events can be compli-
cated by genomic repeats and microhomology of the
inserted sequence, resulting in non-overlapping inser-
tion calls of the same event. To account for this
ambiguity, insertion events are mean-shift clustered at
several scales, with calls from more precise programs
requiring clustering at smaller scales. All clustering
and merging parameters can be adjusted by the user.
A full list of the default parameters can be found in
Supplemental Methods.The BioNano-Irys platform provides outer-boundaries
of reference spans with cumulative sequence-length
differences between the sample compared to the reference.
This differs from other SV detection methods in that a
single Irys call may represent multiple individual
events. For example, a 10 kbp span in the reference with a
sequence-length difference of 1 kbp could represent an
insertion event of 2 kbp and a deletion event of
3 kbp. Irys insertion calls have a mean and median
span to sequence-length difference of 12.4 kbp and
7.7 kbp. Similarly, deletion calls have a mean and median
difference of 18.8 kbp and 13.3 kbp. In order to appropri-
ately incorporate these broad outer-boundaries and
nuanced SV definition, a standard reciprocal overlap or
mean-shift threshold is not an optimal use of the data.
Therefore, we manually inspected the 852 Irys calls
against our merged SVs in order to annotate the SVs as
having additional support provided by Irys.
Spiral Genetics’ Anchored Assembly performs whole
read overlap assembly on corrected, unmapped reads to
detect SNVs, indels, and structural variants. Sequencing
errors are corrected by generating k-mers from reads and
giving each unique k-mer a quality score. Low-scoring
k-mers are discarded as erroneous. The set of high
scoring, or true k-mers is used to construct a de
Bruijn graph representing an error-free reconstruction
of the true read sequences. Each read is corrected by
finding the globally optimum base substitution(s) so
that it aligns to the graph with no mismatches and
differs by the smallest base quality score from the original
read. Of these corrected reads, those that do not match
the reference exactly are assembled into a discontiguous
read overlap graph to capture sequence variation from
the reference. Variants are mapped to human reference
coordinates (GHCr37.p7) by walking the read overlap
graph in both directions until an “anchor” read, where a
continuous 65 bp matches the reference, denotes the
beginning and end of each variant. Where a variant
has more than one anchor, pairing information is
used to determine the correct location of the anchor.
This analysis includes only variants where a variant
was classified as a deletion, insertion, tandem repeat, or
inversion and anchors on both ends mapped uniquely to
the reference. Other variants detected using Anchored
Assembly were not included.
Annotation
Parliament annotates each putative variant with Ensembl
gene boundaries, UCSC gene features (e.g., exon, intron,
UTR), hg19 gap features (telomeres and centromeres),
known variants from DGV, and known repeats from
the UCSC repeat masker track. Known variants are
matched to putative sites if they have at least 50%
reciprocal overlap.
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The Illumina WGS and PacBio data within 2,000 bp of
each variant locus is extracted and locally assembled
with PHRAP. After mapping the resulting contigs back
to the reference with Blasr, we determine whether the
remapped sequence is consistent with the size and type
of the corresponding predicted SV event. We classify
such matches as “valid” SV events. However, local
assembly does not always yield contigs and nor does
it always produce variant alleles. Thus, we also “force
call” events at every variant locus using the PacBio
data, requiring only one PacBio read to be consistent
with the predicted SV event.
SNP concordance
If a deletion occurs within a region that is unique in the
genome, we expect all the SNPs in the deleted region to
be homozygous. For each deletion locus, we calculate
the fraction of homozygous SNVs in a predicted deletion
region (homozScore). We include only deletions that
have at least 5 SNVs in the region (1,633/17,665). We
use the average coverage in the region of <25X (1/2 of
the average HS1011 Illumina coverage) to focus on
deletion regions likely to be unique in the HS1011
genome: average coverage >50X might indicate a paralo-
gous region in HS1011 genome. Since reads from paralogs
sometimes map to the same reference region, they
would result in heterozygous SNVs even if the deletion is
present. We use homozScore of 0.8 instead of 1 to account
for SNV genotyping errors and potential imprecision of
SV breakpoints.
Additional files
Additional file 1: Tables S1–S4, describing the full HS1011 SV data
set, breakpoint comparison, SV/exon intersection, and performance
summary for the Illumina-Only Parliament workflow, respectively.
Additional file 2: Figures S1–S3, describing PCR amplification of
CNV breakpoints and segregation in a family quartet, de novo CNV
analysis, and single molecule assembly, respectively.
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